Thalamic neurometabolic alterations in tremulous Parkinson's disease: A preliminary proton MR spectroscopy study-Reference-Cited by-同舟云学术

Thalamic neurometabolic alterations in tremulous Parkinson's disease: A preliminary proton MR spectroscopy study

Published:2017-10 Issue: Volume:43 Page:78-84
ISSN:1353-8020
Container-title:Parkinsonism & Related Disorders
language:en
Short-container-title:Parkinsonism & Related Disorders

Author:

Barbagallo Gaetano,Arabia Gennarina,Morelli Maurizio,Nisticò Rita,Novellino Fabiana,Salsone Maria,Rocca Federico,Quattrone Andrea,Caracciolo Manuela,Sabatini Umberto,Cherubini Andrea,Quattrone Aldo

Funder

MIUR (Ministero Università e Ricerca

Publisher

Elsevier BV

Subject

Clinical Neurology,Geriatrics and Gerontology,Neurology

Reference30 articles.

1. Rest tremor in patients with essential tremor: prevalence, clinical correlates, and electrophysiologic characteristics;Cohen;Arch. Neurol.,2003

2. Reproducibility of proton MR spectroscopic imaging findings;Tedeschi;AJNR Am. J. Neuroradiol.,1996

3. Efficacy of proton magnetic resonance spectroscopy in neurological diagnosis and neurotherapeutic decision making;Lin;NeuroRx,2005

4. Glutamate as a neurotransmitter in the brain: review of physiology and pathology;Meldrum;J. Nutr.,2000

5. Tremor cells in the human thalamus: differences among neurological disorders;Brodkey;J. Neurosurg.,2004

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Distinguishing essential tremor from Parkinson’s disease: clinical and experimental tools;Expert Review of Neurotherapeutics;2024-07-17

2. Region-specific Cerebral Metabolic Alterations in Parkinson’s Disease Patients With/without Mild Cognitive Impairment;Neuroscience;2024-07

3. Multimodal imaging and electrophysiological study in the differential diagnosis of rest tremor;Frontiers in Neurology;2024-05-24

4. Glutamate Signaling in Patients With Parkinson Disease With REM Sleep Behavior Disorder;Neurology;2024-05

5. MRl and MRS hints for the differentiation of cerebellar multiple system atrophy from spinocerebellar ataxia type II;Heliyon;2024-04